Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 686 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
17 Мб
Скачать
CHAPTER 7 General Physiology
181
BOX 7.9 Causes of Fluid Loss in Surgical
Patients
Blood
Trauma
Surgery
Plasma
Burns
Gastrointestinal
Nasogastric aspiration
Vomiting
Diarrhoea
Intraluminal:
intestinal obstruction
paralytic ileus
Fistulae
Stomas
Exudate in peritoneal cavity
Peritonitis
Acute pancreatitis (also into the retroperitoneum)
Septicaemia
Excess insensible loss
Fever
Sweating
Hyperventilation
Blood and Plasma
• Blood loss may be rapid, the loss of 1 L causing hypoten­sion and hypovolaemic shock.
• Blood is normally replaced by blood, but initially plasma expanders such as gelatin solutions are used until cross­matched blood is available.
• Less rapid haemorrhage allows time for the loss to be replaced from the extracellular extravascular com­partment.
• Greater volumes may be lost slowly before the circula­tion is compromised.
• Plasma lost from severe burns is replaced by plasma, the anticipated losses being replaced according to a stan­dard formula.
Gastrointestinal Losses
• 6–10 L of electrolyte-rich uid are secreted in the upper GI tract daily (Table 7.3).
• Most of this is reabsorbed lower down in the intestine.
• Abnormal uid losses must be measured or estimated as accurately as possible.
• With sequestration of uid in the bowel lumen, e.g. in ileus, only an estimate can be made, but with stulae the amount can be measured accurately and its electro­lyte content assessed.
• As a general rule, gastrointestinal uid loss should be replaced with normal saline with the addition of potas­sium as necessary.
• Regular assessment of serum electrolytes will provide information regarding their requirements.
Intraperitoneal Fluid Loss
• Peritonitis and acute pancreatitis will result in loss of uid into the peritoneal cavity.
• In pancreatitis, uid is also lost into the retroperitoneum.
• ese losses should be made good by plasma substitutes and normal saline.
Septicaemia
• Septic shock associated with peripheral vasodilatation causing relative hypovolaemia.
• Large increase in capillary permeability results in exten­sive loss of protein and electrolytes into the extracellular space.
• is loss combined with peripheral vasodilatation results in collapse and shock.
• Fluid replacement is with plasma expanders and normal saline.
• Exact uid loss is dicult to estimate but should be monitored by:
• urine output
• blood pressure
TABLE 7.3 Normal Daily Gastrointestinal Secretion Volumes and Electrolyte Composition
Secretion Volume (L) Na+ (mmol/L) K+ (mmol/L) Cl− (mmol/L) HCO3 (mmol/L)
Saliva 1–1.5 20–80 10–20 20–40 20–160
Gastric juice 1–2.5 40–100 5–10 120–140 0
Bile 0.5–1.5 140–200 5–10 40–60 20–60
Pancreatic juice 1–2 130 5–10 10–60 80–120
Succus entericus 2–3 140 5 variable variable
182
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
SECTION II Physiology
• central venous pressure (CVP)
• pulmonary wedge pressure monitoring.
Excessive Insensible Fluid Loss
• Insensible uid loss may be greatly increased in the ill patient.
• Pyrexia increases insensible losses by about 10% for each °C rise in temperature.
• Loss is chiey from the lungs as expired water vapour.
• Excessive sweating causes loss of sodium-rich uid, sweat containing about 50mEq Na+/L
• May be overlooked in the pyrexial patient in hot, humid ward in summer months.
COLLOID AND CRYSTALLOID SOLUTIONS
Colloids are osmotically active particles in solution.
Types
• Albumin: human albumin solution.
• Dextran: dextran 70 in 0.9% saline or 5% glucose.
• Gelatin: polygeline (Haemaccel); succinylated gelatin (Gelofusin).
• Hydroxyethyl starch: hetastarch (Hespan).
• Pentastarch (Pentaspan).
Uses
• Maintenance of plasma volume.
• Acute replacement of plasma volume decit.
• Short-term volume expansion (gelatin, dextran).
• Medium-term volume expansion (albumin, pentastarch).
• Long-term volume expansion (hetastarch).
• Interferes with coagulation (factor VIII; inhibits plate­let aggregation).
• Relatively high incidence of allergic reactions.
Gelatins
• Prepared by hydrolysis of bovine collagen.
• Do not aect coagulation per se.
• Low incidence of allergic reactions.
• Small average particle size; therefore, stay in intravascu­lar space shorter period of time.
• Polygeline (Haemaccel):
• contains K+; also contains Ca2+, which can cause
coagulation if mixed with citrated blood in giving set
• stays shorter time in circulation.
• Succinylated gelatin (Gelofusin):
• larger molecular weight than polygeline; therefore,
slightly longer eect
• does not contain calcium.
Hydroxyethyl Starch
• Longer half-life in plasma.
• 10% solutions hyperoncotic; hence increasing plasma volume by more than volume infused.
• Hetastarch (Hespan):
• 6% in saline has largest molecular weight of any plasma
expander and therefore stays in circulation longer
• most useful in capillary leak
• may cause coagulopathy
• high degree of protection from metabolism.
• Pentastarch (Pentaspan):
• lower degree of protection from metabolism
• shorter-lasting eect than Hetastarch.
Albumin
• 5% and 20% human albumin solution.
• Used for replacement of plasma protein and expansion of plasma volume.
• No evidence that maintenance of plasma albumin levels, as opposed to maintenance of plasma colloid osmotic pressure with artificial plasma substitutes, is advantageous.
• 20% albumin used for replacement of plasma protein:
• in severe hypoproteinaemia in renal or liver disease
• aer large-volume paracentesis
• aer massive liver resection.
• Some leaks through capillary membrane (in patients with capillary leak).
• Suppresses albumin synthesis.
Choice of Plasma Expanders
• Succinylated gelatin (Gelofusin) has most advantages in acute hypovolaemia:
• short-acting
• useful until blood becomes available
• no calcium; therefore, does not cause coagulation if
mixed with citrated blood in giving set
• cheap.
• Hetastarch (Hespan):
• has most advantages in chronic (continuing) hypo-
volaemia
• longer-acting
• larger molecules better retained in circulation when
capillaries leaky, e.g. septic shock
• high degree of protection from metabolism.
Dextran
• Glucose polymers of dierent molecular weights.
• Dextran 70 formerly popular as plasma substitute.
• Interferes with cross-matching.
General Problems of Plasma Expanders
• Dilution coagulopathy.
• Allergic reactions.
CHAPTER 7 General Physiology
1/5
1/5
TABLE 7.4 Composition of Common Crystalloid Solutions
Hartmann's
mmol/L N Saline
+
Na
+
K
++
Ca
Cl
HCO
3
Osmolality (mosmol/L) 308 280 284 278 300
a
In the form of lactate which is metabolized to bicarbonate in the liver.
155 131 30 0 150
0 5 0 0 0
0 2 0 0 0
155 111 30 0 0
0 29
Solution
a
4% Dextrose/
N Saline
0 0 150
5% Dextrose
183
Sodium Bicarbonate (1.26%)
• Interfering with cross-matching (dextran 70).
• Persistence of colloid eect dependent on molecular size and protection from metabolism.
• All articial colloids are polydisperse, i.e. there is a range of molecular sizes.
Crystalloids
Crystalloids are salt ions in water.
Common Types
• Normal saline (0.9%).
• 4% dextrose/(
• Glucose, e.g. 5% glucose or stronger solutions.
• Sodium bicarbonate, e.g. 1.26%, 8.4%.
• Potassium chloride. e content of these solutions is shown in Table 7.4.
Uses
• Provision of daily requirements of water and electrolytes.
• Plasma volume should be replaced with colloids, since crystalloids are rapidly lost from plasma.
• Of a volume of crystalloid infused initially, one-third stays in intravascular compartment and two-thirds pass to ECF; therefore, risk of oedema if excessive infusion.
• Advantage that ECF decit is replaced in shock.
• 5% glucose is used to supply intravenous water require­ments, 50 g/L glucose being present to ensure an iso­tonic solution.
• Hartmann’s solution has no practical advantages over
0.9% saline for uid maintenance; however, may be use­ful if large volumes of crystalloid are exchanged (e.g. during continuous haemoltration) to maintain acid– base balance.
• Higher concentrations of glucose are used to prevent or treat hypoglycaemia.
) normal saline.
• Sodium bicarbonate is used to correct metabolic acidosis.
• Potassium chloride is used to supplement K+ in crystal­loid uids. Safety rules for giving K+ include:
• urine output of at least 40 mL/h
• not more than 40 mmol to be added to 1 L of uid
• infusion rate no faster than 40 mmol/h.
OEDEMA AND LYMPHATIC FUNCTION
Oedema is an increase in the volume of interstitial uid above normal levels.
• A hydrostatic pressure difference across the capil­lary endothelium results in flow from vessel to tissue space.
• Retention of plasma proteins within the vasculature is an opposing force, i.e. the plasma oncotic pressure.
• e Starling equilibrium describes the relationship between hydrostatic pressure, oncotic pressure (colloid osmotic pressure) and uid ow across the capillary membrane.
• e Starling equilibrium states:
• capillary hydrostatic pressure + tissue oncotic pres-
sure (pressure tending to drive uid out of the cap­illary) = interstitial uid pressure + plasma oncotic pressure (pressure tending to hold uid into the capillary).
e Starling equilibrium across the capillary is shown
in Fig. 7.1. Filtration is favoured at the arterial end of the capillary, while absorption is favoured at the venous end of the capillary. Any uid not reabsorbed from the intersti­tium by the capillaries is returned to the circulation by the lymphatic system.
Causes of Oedema
Causes of oedema are:
• Increased capillary hydrostatic pressure:
184
Arterial end
Net hydrostatic
Interstitial
Interstitial
Interstitial
Venous end
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Fig. 7.1 Starling equilibrium across capillary.
SECTION II Physiology
Hydrostatic
pressures
(mmHg)
Colloid
osmotic
pressures
(mmHg)
and colloid
osmotic
pressures
(mmHg)
32 12
0 0
32 12
25 25
5 5
20 20
12 8
Filtration
Reabsorption
Blood
fluid
Blood
fluid
Blood
fluid
• chronic right heart failure
• venous obstruction
• increased uid volume (e.g. overtransfusion).
• Decreased plasma oncotic pressure due to hypopro­teinaemia:
• starvation
• cirrhosis
• nephrotic syndrome.
• Increased capillary permeability:
• inammatory reactions
• allergic reactions.
• Increased tissue oncotic pressure:
• lymphatic blockage
• protein accumulation in burns.
Obstruction to Lymphatics
Lymphatics remove protein and excess uid that has been ltered at the arterial end of the capillary and not reab­sorbed at the venous end. If lymphatics are obstructed, then this uid cannot return to the vascular system and accumu­lates behind the obstruction, causing oedema. Lymphatic obstruction may occur due to lymph node pathology as a result of:
• surgical removal, e.g. axillary clearance with mastec­tomy or block dissection
• metastatic tumours
• irradiation
• lariasis.
OSCE SCENARIOS
OSCE Scenario 7.1
A 64-year-old male is admitted for a right hemicolectomy and is found to have a serum sodium of 120 mmol/L.
1. What are the possible causes of hyponatraemia in this
patient?
2. Describe what investigations you would carry out in
order to identify the cause of the hyponatraemia.
3. How would you correct it?
OSCE Scenario 7.2
An 82-year-old male is transferred to ITU following a Hartmann’s procedure for perforated diverticular disease. He has been anuric for 3 h. A number of uid challenges have been given, achieving a BP of 120/90, pulse of 87 and a CVP of 10. ABG analysis shows a pH of 7.2 and U&Es reveal serum potassium of 7.1 mmol/L.
1. What are the possible causes of hyperkalaemia in this
patient?
2. What are the ECG changes associated with hyper-
kalaemia?
3. What would be your possible treatment options for this
patient? Explain how each works to lower the serum potassium.
OSCE Scenario 7.3
A 56-year-old male is admitted with severe dehydration and vomiting. His urea came back raised at 15 mmol/L and his creatinine level was at 215µmol/L. A blood gas analysis shows the following abnormalities – pH 7.55, PO2 10.9kPa, CO2 6.9kPa and HCO3 is 21.
1. What type of metabolic abnormality is this patient
displaying?
2. How has it occurred?
3. e patient has a ‘sucussion splash’ on examination.
What is the diagnosis?
4. How would you manage this condition?
CHAPTER 7 General Physiology
185
OSCE Scenario 7.4
A 35-year-old female patient with weight of 70 kg underwent uncomplicated appendicectomy. As she arrives back to the ward, the nurses ask you to prescribe her intravenous uids for the next 24 h as she is unable to eat and drink due to nausea.
1. What are the volumes of the uid compartments of the
body?
2. In general, what are the average daily uid and electro-
lyte requirements?
3. What intravenous uids would you prescribe for the
looks very unwell and is in obvious pain and is very con­fused. He is wearing a medical alert bracelet informing you he is diabetic. He has a temperature of 39°C and his blood pressure is 90/50 with a heart rate of 110. He has a rather strange smell of acetone or ‘pear drop’ sweets.
1. What is the diagnosis?
2. What would you expect his blood gases to show and
why?
3. How would you manage this patient, explaining which
electrolyte needs specic management?
next 24 h?
Answers in Appendix pages 444–446
OSCE Scenario 7.5
A 65-year-old male patient is brought to the Accident and Emergency department with acute abdominal pain. He
Please check your eBook at https://studentconsult.inkling.com/ for more self-assessment questions. See inside cover for registration details.
8
Airflow
e
PP R
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Respiratory System
INTRODUCTION
Components
e respiratory system is composed of:
• Nasal passages.
• Olfactory system.
• Conducting airways:
• nasopharynx
• larynx
• trachea
• bronchi
• bronchioles
• respiratory portions of the lung (alveoli).
Function
e functions of the respiratory system include:
• cleaning of inhaled air
• warming or cooling of inhaled air
• moistening of inhaled air
• respiratory gas exchange
• facilitation of olfaction and sound production.
Airway Function
e airways have three main functions:
• passage of inhaled gases
• protection against inhaled foreign material
• warming and humidication of inhaled gases.
• Passage of inhaled gases:
• the ow of gases depends on the pressure gradient between the atmosphere and the alveoli
AlveoliAtmospher
(V )
=
V: rate of airow P: pressure R: resistance
• the smooth muscle within the bronchi and bronchi­oles can inuence airow
• bronchoconstriction, under parasympathetic con­trol, leads to an increase in resistance (R) and thus a decrease in airow
• bronchodilatation, under sympathetic control, leads to a decrease in resistance (R) and thus an increase in ai row.
• Protection against inhaled foreign material:
• inhaled air is ltered by the nasal hairs
• any particles passing through the nose become trapped on the mucus coating the airways
• motile cilia lining the airways transport the mucus to the pharynx, where it is swallowed
• the epiglottis closes during swallowing, thus pre­venting food matter from entering the airways
• if any food matter is inhaled, it stimulates a reex cough that will expel the material.
• Warming and humidifying gases:
• as inhaled air passes through the respiratory sys­tem, it is warmed and saturated with water vapour; this produces a water vapour pressure of 6.3 kPa (47 mmHg) at 37°C.
MECHANICS OF VENTILATION
Pulmonary Ventilation
• At the beginning of inspiration the intrapleural pressure is around 4 cmH2O.
• Contraction of the respiratory muscles increases the volume of the chest; this decreases the intrapleural pres­sure to about 9 cmH2O.
• e change in intrapleural pressure causes the lungs to expand, and thus generates a negative intra-alveolar pressure as the alveoli are pulled open.
• As the atmospheric pressure is higher and air ows from high to low pressure, air is inhaled (approxi­mately 500 mL air during quiet ventilation).
• During exercise, other accessory muscles of respiration are used and can generate more negative intrapleural pressures, i.e. 30 cmH2O. Pressures of this magnitude can lead to the inhalation of 2–3 L of air.
186
CHAPTER 8 Respiratory System
Inspiration
Pressure (cmH
O) Pressure (cmH
O)
Expiration
Volume (mL)
–20
187
• Expiration is a passive process due to the elastic recoil of the chest wall.
• During exercise, contraction of internal intercostals and abdominal muscles can generate intrapleural pressures as high as +20 cmH2O to expel air more rapidly.
Lung Pressures (Fig. 8.1)
• ere are three forces acting on the lung:
• elastic nature of the lungs: under normal conditions
the lungs are stretched; this results in a force that pulls inwards on the visceral pleura
• surfactant: lines the alveoli and exerts an inward or
collapsing pressure
• negative intrapleural pressure: opposes the above
two forces. is negative pressure is created by the chest wall and diaphragm pulling the parietal pleura outwards. As the two layers of pleura are pulled in opposite directions, they generate a nega­tive pressure.
• e pressure in the alveoli equals the atmospheric pressure as they are both in direct contact via the air­ways; atmospheric pressure is zero and the intrapleural
4.0
3.5
3.0
Volume (L)
A
2.5
+2
Fig. 8.1 Graphs demonstrating the relationship bet-
ween (A) lung volume, (B) intrapleural, and (C) intra­alveolar pressure during normal quiet respiration. (From McGeown JG. Physiology, 2nd edn. Churchill Livingstone, Edinburgh, 2000, with permission.)
0
–10
–2
–4
–6
–8
+1
0
–1
2
B
2
C
pressure is between 4 and 9 cmH2O. is produces the transmural or transpulmonary pressure; it is this that keeps the lungs distended.
Surfactant and Surface Tension (Fig. 8.2)
• Phase 1: it takes a considerable pressure increase before there is a change in volume.
• Phase 2: expansion of the lung is proportional to the increase in pressure.
• Phase 3: maximum capacity.
• Phase 4: in the initial stage the lung volume is maintained until the pressure has fallen considerably (approximately 8 cmH2O).
• e unequal pressure needed to maintain a given lung volume in inspiration and expiration is called hysteresis.
• Surfactant is a phospholipid-rich detergent produced by type II alveolar cells; it coats the luminal surface of alveoli and produces a force called surface tension.
• Surface tension is present at all air–uid interfaces.
• Surface tension occurs because water molecules are attracted more to each other than they are to gas mole­cules. When any liquid surrounds a gas, i.e. in the alveo­lus, this produces an inward pressure.
• Lungs inated with normal saline do not exhibit hyster­esis; there is no air–uid interface, so there is no surface tension; the only force opposing expansion is the elas­ticity of the lung parenchyma.
Inflation with
saline
200
150
100
50
0
0 –10
Phase 4
Phase 1
Pressure (cmH2O)
Fig. 8.2 Graph illustrating the differences in compli-
ance between the lungs inflated with air and the lungs inflated with saline. The greater compliance in saline­filled lungs is explained by the lack of surface tension.
Inflation with
air
Phase 3
Phase 2
188
T
r
Co
mL/cmHO
=
100
2
Volume above FRC (L)
0.5
2
–10
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
SECTION II Physiology
• In air-inated lungs the surface tension at the air–uid interface opposes expansion; surface tension accounts for almost two-thirds of the elastic recoil of the lungs.
• Surfactant has several other functions:
• by lowering the surface tension, surfactant increases
compliance and reduces the work of breathing
• prevents uid accumulating in the alveoli
• reduces the tendency of alveoli to collapse (alveolar
instability).
• Alveolar instability is related to changes in alveolar diameter and can be explained by the law of Laplace:
0.4
0.3
0.2
0.1
Expiration
Compliance
Inspiration
• As alveoli decrease in size, the radius (r) will tend to
• As the alveolar radius decreases, then the concentration
Compliance (Fig. 8.3)
• Compliance is the ease with which the lungs can be
• Two principal factors govern compliance:
• Normal lungs have high compliance as the elastic tis-
• Conditions which decrease compliance include:
P
ΔP: alveolar distending pressure T: surface tension r: radius
increase (assuming surface tension [T] remains con­stant). If surfactant were not present, this would mean that pressure would be greater in small alveoli and lower in larger alveoli; this would result in collapse of the alve­oli as air moves from the smaller to the larger alveoli.
of surfactant increases and thus reduces surface tension (T). erefore, surface tension and radius increase or decrease in tandem and this results in very little change in alveolar pressure.
inated:
mpliance
=
=
∆VP
500
5
cmHO
mL
2
ΔV: change in volume ΔP: change in pressure compliance means lungs are easy to expand. compliance means lungs resist expansion.
• elasticity of the lung parenchyma
• surface tension.
sue is easily stretched and surfactant reduces surface tension.
• scarring or brosis of lung parenchyma
0
–1 –2 –3 –4 –5 –6 –7 –8 –9
Pressure (cmH
O)
Fig. 8.3 Pressure–volume curve for a single respi-
ratory cycle. It represents the volume change if the work of respiration was against elastic resistance only. To the right of the compliance line represents the additional pressure required to overcome airflow resistance and other resisting forces. To the left of the compliance line is the work required during passive expiration. (From Pocock G & Richards CD. Human Physiology: The Basis of Medicine, 2nd edn. Oxford University Press, Oxford, 2004, with permission.)
• pulmonary oedema
• deciency of surfactant, e.g. premature babies
• decreased lung expansion, e.g. respiratory muscle paralysis
• supine position
• mechanical ventilation (due to reduced pulmonary blood ow)
• age
• breathing 100% O2.
• Conditions which increase compliance include:
• emphysema (due to destruction of elastic bres in the lung parenchyma).
Respiratory Muscles
See Anatomy section (Chapter 1).
Work of Breathing (Fig. 8.4)
• Work of breathing is the work required to move the lung and chest wall.
• During inspiration, work consists of two components:
• work needed to overcome the elastic forces of the
chest wall and lungs
• work needed to overcome non-elastic forces of the
chest wall and lungs.
CHAPTER 8 Respiratory System
1.0
resistance, friction and
189
Work against
elastic
elements
X
Volume above FRC (L)
2 0 –2 –4 –6 –8 –10
A
Change in pressure (cmH2O)
Y
Work against airways
inertia
X = Work of expiration X + Y = Work of inspiration
• Non-elastic forces include:
• airway resistance (most signicant)
• frictional forces
• inertia of the air and tissues.
• One-third of airway resistance occurs in the upper airways – nose, pharynx and larynx. is can be greatly reduced by breathing through the mouth (e.g. during exercise).
• Two-thirds of the resistance is in the tracheobronchial tree, mainly in the medium-sized bronchi (high ow but low cross-sectional area).
• Resistance in the terminal bronchioles is very low due to the high cross-sectional area.
• Resistance falls as the volumes of the lungs increase;
1.0
X
Y
the elastic parenchyma pulls open bronchioles and thus resistance decreases.
Regional Variations in Ventilation (Fig. 8.5)
• In the upright position the lung is not evenly ventilated; the upper parts are not ventilated as well as the lower parts.
• ere are two reasons to explain this:
Volume above FRC (L)
• the weight of the lungs
• the compliance curve is sigmoid, and the upper and
lower parts of the lung lie on dierent parts of this
2 0 –2 –4 –6 –8 –10
B
Change in pressure (cmH
O)
2
curve.
• Transpulmonary pressure is the dierence between the intrapleural pressure and the alveolar pressure.
• During phase 1, when the lung volume is near resid-
1.0
C
X
ual volume, the compliance is low, thus it takes a large change in pressure to cause a change in volume.
• In phase 2, the compliance is at its maximum and lung volume increases linearly with an increase in pressure.
• In phase 3, the compliance falls as the lungs become fully expanded.
• e lower parts of the lungs lie on the diaphragm and
Volume above FRC (L)
are compressed, whereas the upper parts are already stretched by their own weight; therefore, ination begins further along the pressure–volume curve.
2 0 –2 –4 –6 –8 –10
C
Change in pressure (cmH
O)
2
Fig. 8.4 (A) Graph demonstrating the work of respira-
tion. The increasing volume above functional residual capacity (FRC) is plotted against the change in intra­pleural pressure. The work of inspiration is greater than expiration. Energy for expiration is from the stretch­ing of elastic lung tissue. (B) The increased pressure required to move an equal volume of air with reduced lung compliance. (C) The increased resistance to expi­ration and increased energy required to expire a simi­lar volume of air in a patient with increased airways resistance. (From Pocock G & Richards CD. Human Physiology: The Basis of Medicine, 2nd edn. Oxford University Press, Oxford, 2004, with permission.)
Clinical Physiology
Pneumothorax
ere are a number of types of pneumothorax:
Spontaneous (primary) pneumothorax
• Occurs in young males. e cause is unknown; there is rarely any associated respiratory disease. Occasionally the patient has Marfan’s syndrome with an associated apical pleural bleb.
Spontaneous (secondary) pneumothorax
• Occurs in patients due to underlying respiratory pathol­ogy; causes include:
• asthma
• chronic obstructive pulmonary disease (COPD)
190
100
Transpulmonary pressure
% Lung volume
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
SECTION II Physiology
90
80
70
60
50
40
30
20
10
FRC
0
X
0 15 30
V
P
V
P
O
cmH
2
Fig. 8.5 Pressure–volume curve for lung inflation and its influence on the distribution of ventilation during
inspiration from functional residual capacity (FRC).
• cancer
• lung abscess.
Traumatic (closed) pneumothorax
• Iatrogenic, e.g. mechanical ventilation or lung biopsy.
• Non-iatrogenic, e.g. stab wound or road trac accident.
Tension pneumothorax
• A pneumothorax occurs when air enters the pleural space due to the disruption of either the visceral (rup­tured pleural bleb) or parietal pleura (stab wound).
• e air entering the pleural space leads to loss of the negative intrapleural pressure and thus the lung col­lapses; this is the type of pneumothorax seen in spon­taneous and traumatic closed pneumothoraces.
• In a tension pneumothorax the lung injury may form
Pulmonary Assessment
Lung Volumes (Table 8.1)
• Lung volumes can be measured using a spirometer.
• e denition of each lung volume is as follows:
• tidal volume (TV): the air taken in and exhaled dur­ing quiet breathing
• inspiratory reserve volume (IRV): the maximum volume of air that can be inspired in excess of normal inspiration
• expiratory reserve volume (ERV): the maximum amount of air that can be forcefully expired aer normal expiration
• functional residual capacity (FRC): the volume of gas le in the lungs aer expiration during normal breathing
a valve in which air leaks into the pleural cavity dur­ing inspiration but closes during expiration; this leads to a positive intrapleural pressure (can be as high as 20 cmH2O), and pushes mediastinal structures into the opposite side of the chest.
Open pneumothorax or ‘sucking’ chest wound
• In an open pneumothorax there is a defect in the chest wall, e.g. due to a gunshot wound; this allows intrathoracic pressure to equalize with atmospheric pressure. If the defect is greater than two-thirds of the diameter of the trachea then air will preferentially enter through the hole in the chest wall as this is the path of least resistance; this leads to impaired ventila­tion and hypoxia.
TABLE 8.1 Values for Respiratory
Variables in a Healthy Adult Male
Lung Volume Value (L)
Total lung volume 6.0
Vital capacity 4.8
Residual volume 1. 2
Tidal volume 0.5
Functional residual capacity 2.2
Inspiratory capacity 3.8
Expiratory reserve volume 1. 0